NRG oncology study of atezolizumab and chemoradiation for patients with limited-stage small cell lung cancer completes accrual
The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for